Jeremy S Mogridge

Title: The Innovations of Jeremy S Mogridge

Introduction

Jeremy S Mogridge is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of biotechnology, particularly in relation to anthrax toxin receptor polypeptides. With a total of two patents to his name, Mogridge's work has implications for both human and animal health.

Latest Patents

Mogridge's latest patents focus on mammalian anthrax toxin receptor polypeptides and the polynucleotides encoding them. These inventions include vectors containing the polynucleotides and polypeptides, as well as host cells that contain related polynucleotide molecules. His work also addresses cells that do not display anthrax toxin receptors on their exterior surfaces, including minus cell lines and animals. Furthermore, Mogridge's patents provide methods for identifying molecules that bind to the anthrax toxin receptor and those that can reduce the toxicity of anthrax toxin. These innovations are crucial for developing treatments for both human and non-human animals suffering from anthrax.

Career Highlights

Throughout his career, Mogridge has worked with esteemed organizations such as the Wisconsin Alumni Research Foundation and Harvard College. His experience in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Mogridge has collaborated with notable individuals in his field, including John A T Young and Kenneth A Bradley. These partnerships have likely enriched his research and expanded the impact of his inventions.

Conclusion

Jeremy S Mogridge is a distinguished inventor whose work on anthrax toxin receptor polypeptides has the potential to improve health outcomes for both humans and animals. His contributions to biotechnology are noteworthy and reflect his commitment to innovation in the field.